Scientists are studying a potential new approach to curing epilepsy and depression at the same time, to be treated with drugs called DNMT inhibitors (e.g., decitabine and azacytidine) that are molecular erasers of unnecessary chemical marks on DNA [232]. The gene discussed is DNMT1; the disease is major depressive disorder.